Globus Medical Inc (GMED)
70.66
+0.62
(+0.89%)
USD |
NYSE |
Oct 04, 16:00
70.64
-0.02
(-0.03%)
After-Hours: 20:00
Globus Medical SG&A Expense (Annual): 643.41M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 643.41M |
| December 31, 2022 | 432.12M |
| December 31, 2021 | 408.15M |
| December 31, 2020 | 354.76M |
| December 31, 2019 | 354.76M |
| December 31, 2018 | 311.59M |
| December 31, 2017 | 267.82M |
| December 31, 2016 | 222.16M |
| Date | Value |
|---|---|
| December 31, 2015 | 210.24M |
| December 31, 2014 | 188.63M |
| December 31, 2013 | 182.52M |
| December 31, 2012 | 168.86M |
| December 31, 2011 | 140.39M |
| December 31, 2010 | 122.59M |
| December 31, 2009 | 108.42M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
354.76M
Minimum
2019
643.41M
Maximum
2023
438.64M
Average
408.15M
Median
2021
SG&A Expense (Annual) Benchmarks
| Boston Scientific Corp | 5.19B |
| Haemonetics Corp | 431.78M |
| Stryker Corp | 7.129B |
| Abbott Laboratories | 10.95B |
| Alphatec Holdings Inc | 374.08M |